Grady Grant III
Director · Aptevo Therapeutics Inc.
IndividualBuying only
- 2025
- Aug 11, 2026
- 4
Other insiders active in the same sector
No other insider has filed at Grady Grant III's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- August J. Troendle - $358.45M in MEDP purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- Paul R. Vigano - $268.34M in AVAH purchases and sales in the last 12 months
- Robert M. Williams Jr. - $268.34M in AVAH purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Grady Grant III?
Grady Grant III is a corporate insider, tracked as Director of Aptevo Therapeutics Inc. (APVO). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Grady Grant III submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Grady Grant III been buying or selling stock?
Recorded transactions: 1 open-market purchase ($20K) and 0 open-market sales across all tracked filings.
